REFERENCES
- Lloyd-Jones DM, O'Donnell CJ, D'Agostino RB, Massaro J, Silbershatz H, Wilson PW. Applicability of cholesterol-lowering primary prevention trials to a general population: The Framingham Heart Study. Arch Intern Med. 2001;161:949.
- Kashani A, Phillips CO, Foody JM, Risks associated with statin therapy: A systematic overview of randomized clinical trials. Circulation. 2006;114:2788.
- Keech A, Simes RJ, Barter P, Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomized controlled trial. Lancet. 2005;366:1849–1861.
- Thompson PD, Clarkson PM, Rosenson RS. An assessment of statin safety by muscle experts. Am J Cardiol. 2006;97:69C.
- Antons KA, Williams CD, Baker SK, Phillips PS. Clinical perspectives of statin-induced rhabdomyolysis. Am J Med. 2006;119:400.
- Lees RS, Lees AM. Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole. N Engl J Med. 1995;333:664.
- Knopp RN. Drug treatment of lipid disorders. N Engl J Med. 1999;341:498.
- Grundy SM. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med. 1988;319:24.
- Oldemeyer JB, Lund RJ, Koch M, Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations. Cardiology. 2000;94:127–128.
- Unal A, Torun E, Sipahioglu MH, Fenofibrate-induced acute renal failure due to massive rhabdomyolysis after coadministration of statin in two patients. Intern Med. 2008;47:1017–1019.
- Graham DJ, Staffa JA, Shatin D, Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA. 2004;292:2585–2590.
- Ridker PM, Danielson E, Fonseca FA, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Eng J Med. 2008;359:2195–2207.
- Drug interactions with simvastatin. Med Lett Drugs Ther. 2008;50:83–84.
- Ireland JH, Eggert CH, Arendt CJ, Williams AW. Rhabdomyolysis with cardiac involvement and acute renal failure in a patient taking rosuvastatin and fenofibrate. Ann Intern Med. 2005;142:949–950.